Clinical Trial Update: Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII [NA]

View source ↗

Summary

This ClinicalTrials.gov entry notes an ongoing head-to-head trial comparing the everolimus-eluting SYNERGY stent with the biolimus-eluting Biomatrix NeoFlex ste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Biomatrix NeoFlex stent (biolimus-eluting Biomatrix NeoFlex stent)
• SYNERGY stent (everolimus-eluting) (everolimus-eluting SYNERGY stent)

Snippet

Sponsor: Aarhus University Hospital Skejby | Conditions: Coronary Artery Disease, Ischemic Heart Disease | NA | Status: UNKNOWN